Peanut allergy advance: Oral therapy for allergy desensitization deemed safe for preschool-aged kids

Study found 243 out of 270 peanut-allergic children prescribed oral immunotherapy gradually built up a tolerance, with only 12 requiring epinephrine

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

30 Oct 2017 --- New research presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting suggests that peanut allergy in children has... Read More

FormattedPicture

REGULATORY NEWS

11 Sep 2017 --- The US Food and Drug Administration (FDA) has made a statement on a new qualified health claim advising that early introduction of peanuts to certain high-risk... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

11 Nov 2016 --- The American College of Allergy, Asthma and Immunology (ACAAI) has announced that it will give presentations at the Annual Scientific Meeting to offer guidance on... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

08 Nov 2016 --- Nestlé Health Science has announced that it will make an equity investment of $145 million in US-based Aimmune Therapeutics, to accelerate the development of... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

27 Oct 2016 --- A wearable patch that delivers small amounts of peanut protein through the skin has shown promise for treating children and young adults with peanut allergy,... Read More

trans